Contact
Please use this form to send email to PR contact of this press release:
Intiva Licenses Intellectual Property Related to the Use of Cannaboinoids to Treat Exposure to Nerve Agents
TO:
Jeffrey Friedland
INTIVA Kotzker Pharmaceuticals, Inc.
1 800 497 2915